About us

The Harris Lab uses a large repertoire of model systems and experimental approaches to understand how DNA mutating enzymes (APOBECs) provide immunity against viral infections, yet in many cases also contribute to tumor evolution through genomic DNA mutagenesis. Another goal of the Harris Lab is to translate these fundamental scientific discoveries into novel therapeutics against viruses and cancer.

Recent News

December 1, 2016
Gabriel Starrett wins the 2017 UMN MICaB Outstanding Graduate Student Award. Congratulations Gabe!

November 30, 2016
Dr. Reuben S. Harris recognized by UMN AHC Academies for Excellence. Congratulations!

October 10, 2016
Emily Law and colleagues demonstrate the role of APOBEC3B in cancer drug resistance in the article "The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer" published in Science Advances.

See more...